Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease

E-ISSN： 1875-6190|14|4|339-355

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.14, Iss.4, 2016-05, pp. : 339-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale for current therapies in Parkinson’s disease

By Romrell Janet Fernandez Hubert H Okun Michael S

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1747-1761

Informa Healthcare

Access to resources Recommend Favorite

Emerging Therapies in the Pharmacological Treatment of Parkinsons Disease

By Korczyn A.D. Nussbaum M.

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 775-786

Adis International

Access to resources Recommend Favorite

Existing dopaminergic therapies for Parkinson’s disease

By Dutta PhD Aloke K Le MD PhD Weidong

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1613-1625

Informa Healthcare

Access to resources Recommend Favorite

Emerging and Alternative Therapies For Parkinson Disease: An Updated Review

Current Pharmaceutical Design, Vol. 24, Iss. 22, 2018-06 ,pp. : 2573-2582

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s Disease and Parkinson’s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

Current Pharmaceutical Design, Vol. 24, Iss. 1, 2018-03 ,pp. : 22-45

Bentham Science Publishers

Access to resources Recommend Favorite